PRESS RELEASE published on 05/20/2025 at 15:00, 11 months 14 days ago Exail wins a contract with the Singapore Navy for the supply of multiple robotic systems in the field of mine countermeasures Exail selected to enhance Singapore Navy's mine countermeasures with advanced drone-based solutions. Partnership with ST Engineering for USVs and innovative sonar systems Partnership Exail Mine Countermeasures Singapore Navy Drone-based Solutions
PRESS RELEASE published on 05/20/2025 at 14:59, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Alpha Group International plc The Vanguard Group, Inc. discloses a 1.23% ownership of Alpha Group International plc's 0.2p ordinary securities. Purchase of 3,548 securities at 31.08 GBP per unit The Vanguard Group Inc. Ownership Disclosure Financial Disclosure Securities Purchase Alpha Group International Plc
PRESS RELEASE published on 05/20/2025 at 14:58, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The The Vanguard Group, Inc. discloses a 1.76% stake in PRS REIT plc. Purchase of 57,195 securities at 1.15 GBP per unit Securities The Vanguard Group Purchase Stake Disclosure PRS REIT Plc
PRESS RELEASE published on 05/20/2025 at 14:57, 11 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses a 5.17% stake in Spirent Communications plc per Form 8.3. Purchased 61,465 shares at 1.93 GBP per unit as of 19 May 2025 Form 8.3 The Vanguard Group Financial Investment Shareholder Disclosure Spirent Communications PLC
PRESS RELEASE published on 05/20/2025 at 14:30, 11 months 14 days ago Hear At Last Holdings Receives Initial Purchase Order of Portable Homes from Jamaican Developer Hear At Last Holdings Inc. receives initial order for portable homes from Jamaican developer, marking a milestone in Caribbean market expansion Modular Housing Caribbean Market Portable Homes Hear At Last Holdings Inc. Jamaican Real Estate Developer
PRESS RELEASE published on 05/20/2025 at 14:30, 11 months 14 days ago Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation Aspire Biopharma initiates Phase 1 trial for high-dose aspirin formulation in the United States, targeting accelerated approval with positive data anticipated in 3Q 2025 Accelerated Approval Phase 1 Trial FDA Feedback Aspire Biopharma High-dose Aspirin Formulation
PRESS RELEASE published on 05/20/2025 at 14:30, 11 months 14 days ago Amaze Named Exclusive Merchandise Partner for Ghost Gaming as Creator Economy Expands Amaze Software partners with Resurgens Gaming to launch official merchandise store for Ghost Gaming creators, offering e-commerce solutions and global fulfillment at DreamHack Dallas May 23-25 DreamHack Dallas Merchandise Amaze Software Ghost Gaming Resurgens Gaming
PRESS RELEASE published on 05/20/2025 at 14:30, 11 months 14 days ago Grid Battery Awards Contract for 2025 Exploration Program on its Copper-Gold Property to Hardline Exploration Grid Battery Metals Inc. announces exploration program with Hardline Exploration in BC. Focus on Copper-Gold Project in favorable mining region. Preliminary work planned for 2025 summer season Copper-gold Project British Columbia Grid Battery Metals Inc. Exploration Program Hardline Exploration
PRESS RELEASE published on 05/20/2025 at 14:19, 11 months 14 days ago SAF-HOLLAND looks back on strong operating performance in a challenging market environment – Annual General Meeting 2025 approves all agenda items SAF-HOLLAND SE reports strong operating performance in challenging market environment at the Annual General Meeting 2025. Company approves dividend, elects new Supervisory Board members, and outlines 'drive2030' strategy Annual General Meeting Dividend Operating Performance SAF-HOLLAND SE Drive2030
PRESS RELEASE published on 05/20/2025 at 14:01, 11 months 14 days ago Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis Philikos initiates Phase 1/2 study with T-Guard in systemic sclerosis patients to evaluate safety and efficacy, aiming to offer a less invasive treatment option Clinical Trial Systemic Sclerosis Autoimmune Disorder Philikos T-Guard
Published on 05/02/2026 at 21:00, 1 day ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 20 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 20 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 21 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 21 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 20:10, 1 hour 22 minutes ago A Decade of Learning Across Borders: PKU's South-South Institute Turns 10
Published on 05/03/2026 at 04:45, 16 hours 47 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 5 hours ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days 2 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 3 days 1 hour ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days 2 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days 2 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 days 3 hours ago Minutes of the Combined General Meeting held on April 30, 2026